Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors

Cancer Research

Volumn 57, Issue 21, 1997, Pages 4710-4713

  Dahia, Patricia L M ^a   Marsh, Debbie J ^a   Zheng, Zimu ^a   Zedenius, Jan ^b   Komminoth, Paul ^c   Frisk, Tony ^b   Wallin, Goran ^b   Parsons, Ramon ^d   Longy, Michel ^e   Larsson, Catharina ^b   Eng, Charis ^a,f,g  

^a HARVARD MEDICAL SCHOOL   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e INSTITUT BERGONIÉ   (France)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 10Q; COWDEN SYNDROME; FAMILIAL CANCER; GENE DELETION; GENE MAPPING; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SOMATIC MUTATION; THYROID TUMOR; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA, FOLLICULAR; CARCINOMA, PAPILLARY; FRAMESHIFT MUTATION; GENE DELETION; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; HAMARTOMA SYNDROME, MULTIPLE; HUMANS; THYROID NEOPLASMS;

EID: 0030730905     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Eng, C., Clayton, D., Schuffenecker, I., Lenoir, G., Cote, G., Gagel, R. F., Ploos van Amstel, H. K., Lips, C. J. M., Nishisho, I., Takai, S-I., Marsh, D. J., Robinson, B. G., Frank-Raue, K., Raue, F., Xue, F., Noll, W. W., Romei, C., Pacini, F., Fink, M., Niederle, B., Zedenius, J., Nordenskjöld, M., Komminoth, P., Hendy, G. N., Gharib, H., Thibodeau, S. N., Lacroix, A., Frilling, A., Ponder, B. A. J., and Mulligan, L. M. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: International RET Mutation Consortium analysis. J. Am. Med. Assoc., 276: 1575-1579, 1996.
2. Eng, C., Mulligan, L. M., Smith, D. P., Healey, C. S., Frilling, A., Raue, F., Neumann, H. P. H., Pfragner, R., Behmel, A., Lorenzo, M. J., Stonehouse, T. J., Ponder, M. A., and Ponder, B. A. J. Mutation in the RET proto-oncogene in sporadic medullary thyroid carcinoma. Genes Chromosomes Cancer, 12: 209-212, 1995.
3. Grieco, M., Santoro, M., Berlingieri, M. T., Melillo, R. M., Donghi, R., Bongarzone, I., Pierotti, M. A., Della Porta, G., Fusco, A., and Vecchio, G. PTC is a novel rearranged form of the ret proto-oncogene and is frequently expressed in vivo in human papillary thyroid carcinomas. Cell. 60: 557-563, 1990.
4. Bongarzone, I., Monzini, N., Borrello, M. G., Carcano, C., Ferraresi, G., Arighi, E., Mondellini, P., Della Porta, G., and Pierotti, M. A. Molecular characterisation of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI α of cyclic AMP-dependent protein kinase A. Mol. Cell. Biol., 13: 358-366, 1993.
5. Santoro, M., Dathan, N. A., Berlingieri, M. T., Bongarzone, I., Paulin, C., Grieco, M., Pierotti, M. A., Vecchio, G., and Fusco, A. Molecular characterization of RET/PTC3: a novel rearranged version of the RET proto-oncogene in a human thyroid papillary carcinoma. Oncogene, 9: 509-516, 1994.
6. Califano, D., Monaco, C., de Vita, G., D'Alessio, A., Dathan, N. A., Possenti, R., Vecchio, G., Fusco, A., Santoro, M., and de Franciscis, V. Activated RET/PTC elicits immediate early and delayed response genes in PC12 cells. Oncogene, 11: 107-112, 1995.
7. Borrello, M. G., Alberti, L., Arighi, E., Bongarzone, I., Battistini, C., Bardelli, A., Pasini, B., Puitti, C. Rizetti, M. G., Mondellini, P., Radice, M. T., and Pierotti, M. A. The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cγ. Mol. Cell. Biol., 16: 2151-2163, 1996.
8. Eng, C. Cowden syndrome. J. Genet. Counseling, 6: 181-191, 1997.
9. Longy, M., and Lacombe, D. Cowden disease. Report of a family and review. Ann. Genet., 39: 35-42, 1996.
10. Nelen, M. R., Padberg, G. W., Peeters, E. A. J., Lin, A. Y., van den Helm, B., Frants, R. R., Coulon, V., Goldstein, A. M., van Reen, M. M. M., Easton, D. F., Eeles, R. A., Hodgson, S., Mulvihill, J. J., Murday, V. A., Tucker, M. A., Mariman, E. C. M., Starink, T. M., Ponder, B. A. J., Ropers, H. H., Kremer, H., Longy, M., and Eng, C. Localization of the gene for Cowden disease to 10q22-23. Nat. Genet., 13: 114-116, 1996.
11. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S. H., Giovanella, B. C., Ittman, M., Tycko, B., Hibshoosh, H., Wigler, M. H., and Parsons, R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer. Science (Washington DC), 275: 1943-1947, 1997.
12. Li, D-M., and Sun, H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor β. Cancer Res., 57: 2124-2129, 1997.
13. Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., Frye, C., Hu, R., Swedlund, B., Teng, D. H. F., and Tavtigian, S. V. Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet., 15: 356-362, 1997.
14. Myers, M. P., Stolarov, J., Eng, C., Li, J., Wang, S. I., Wigler, M. H., Parsons, R., and Tonks, N. K. PTEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc. Natl. Acad. Sci. USA, 94: 9052-9057, 1997.
15. Liaw, D., Marsh, D. J., Li, L, Dahia, P. L. M., Wang, S. I., Zheng, Z., Bose, S., Call, K. M., Tsou, H. C., Peacocke, M., Eng, C., and Parsons, R. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet., 16: 64-67, 1997.
16. Marsh, D. J., Dahia, P. L. M., Zheng, Z., Liaw, D., Parsons, R., Gorlin, R. J., and Eng, C. Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat. Genet., 16: 333-334, 1997.
17. Marsh, D. J., Dahia, P. L. M., Coulon, V., Zheng, Z., Dorion-Bonnet, F., Call, K. M., Little, R., Lin, A. Y., Eeles, R. A., Goldstein, A. M., Hodgson, S. V., Richardson, A-L., Robinson, B. G., Weber, H. C., Longy, M., and Eng, C. Allelic imbalance, including deletion of PTEN/MMAC1, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden disease. Genes Chromosomes Cancer, in press, 1997.
18. Hedinger, C. E., Williams, E. D., and Sobin, L. H. Histological typing of thyroid tumors. In: WHO'S International Histological Classification of Tumors, Ed. 2. Berlin: Springer-Verlag, 1988.
19. Mathew, C. G. P., Smith, B. A., Thorp, K., Wong, Z., Royle, N. J., Jeffreys, A. J., and Ponder, B. A. J. Deletion of genes on chromosome 1 in endocrine neoplasia. Nature (Lond.), 328: 524-526, 1987.
20. Marsh, D. J., Zheng, Z., Zedenius, J., Kremer, H., Padberg, G. W., Larsson, C., Longy, M., and Eng, C. Differential loss of heterozygosity in the region of the Cowden locus within 10q22-23 in follicular thyroid adenomas and carcinomas. Cancer Res., 57: 500-503, 1997.
21. Knudson, A. G. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA, 68: 820-823, 1971.